Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment

Gastric cancer treatment is challenging due to the lack of early-stage diagnostic technology and targeted delivery systems. Currently, the available treatments for gastric cancer are surgery, chemotherapy, immunotherapy, and radiation. These strategies are either invasive or require systemic delivery, exerting toxicities within healthy tissues. By creation of a targeted delivery system to the stomach, gastric cancer can be treated in the early stages. Such an approach reduces the negative effects on the rest of the body by minimizing systemic absorbance and random localization. With this in mind, we developed a mucoadhesive vehicle composed of β-Glucan And Docosahexaenoic Acid (GADA) for controlled drug/gene delivery. In the current study, we investigated the therapeutic effect of codelivery Bcl2 inhibitors navitoclax (NAVI) and siRNA (Bcl2) via oral using GADA. The therapeutic efficacy of the GADA-mediated oral NAVI/siRNA was investigated in a gastric cancer mouse model. Higher Bcl2 inhibition efficacy was observed in Western blotting and TUNEL assay in mice treated with GADA/NAVI/siRNA compared to free NAVI, siRNA, and NAVI/siRNA. Histology (H&E) and immunohistochemistry (Ki67, TUNEL, and BCl2) analyses confirmed a significant reduction of the tumor region. Interaction between GADA and mucus resulted in retention for over 6 h and thereby sustained local payload release. The developed oral carrier GADA is an emerging vehicle that has promising potential in oral delivery of both small and large molecules, and their mucoadhesive property results in improved therapeutic efficacy with minimal side effects compared to conventional treatment. This study opens a new window for the effective delivery of oral medicine for the treatment of gastric cancer and other gastrointestinal diseases.

Myofibroblast specific targeting approaches to improve fibrosis treatment

Fibrosis has been shown to develop in individuals with underlying health conditions, especially chronic inflammatory diseases. Fibrosis is often diagnosed in various organs, including the liver, lungs, kidneys, heart, and skin, and has been described as excessive accumulation of extracellular matrix that can affect specific organs in the body or systemically throughout the body. Fibrosis as a chronic condition can result in organ failure and result in death of the individual. Understanding and identification of specific biomarkers associated with fibrosis has emerging potential in the development of diagnosis and targeting treatment modalities. Therefore, in this review, we will discuss multiple signaling pathways such as TGF-β, collagen, angiotensin, and cadherin and outline the chemical nature of the different signaling pathways involved in fibrogenesis as well as the mechanisms. Although it has been well established that TGF-β is the main catalyst initiating and driving multiple pathways for fibrosis, targeting TGF-β can be challenging as this molecule regulates essential functions throughout the body that help to keep the body in homeostasis. We also discuss collagen, angiotensin, and cadherins and their role in fibrosis. We comprehensively discuss the various delivery systems used to target collagen, angiotensin, and cadherins to manage fibrosis. Nevertheless, understanding the steps by which this molecule drives fibrosis development can aid in the development of specific targets of its cascading mechanism. Throughout the review, we will demonstrate the mechanism of fibrosis targeting to improve targeting delivery and therapy.

Identification of cotton fleahopper (Hemiptera: Miridae) host plants in central Texas and compendium of reported hosts in the United States

The cotton fleahopper, Pseudatomoscelis seriatus (Reuter), is an early-season pest of developing cotton in Central Texas and other regions of the Cotton Belt. Cotton fleahopper populations develop on spring weed hosts and move to cotton as weed hosts senesce or if other weed hosts are not readily available. To identify weed hosts that were seasonably available for the cotton fleahopper in Central Texas, blooming weed species were sampled during early-season (17 March-31 May), mid-season (1 June-14 August), late-season (15 August-30 November), and overwintering (1 December-16 March) periods. The leading hosts for cotton fleahopper adults and nymphs were evening primrose (Oenothera speciosa T. Nuttall) and Mexican hat [Ratibida columnifera (T. Nuttall) E. Wooton and P. Standley], respectively, during the early season. During the mid-season, silver-leaf nightshade (Solanum elaeagnifolium A. Cavanilles) was consistently a host for fleahopper nymphs and adults. Woolly croton (Croton capitatus A. Michaux) was a leading host during the late season. Cotton fleahoppers were not collected during the overwintering period. Other suitable hosts were available before previously reported leading hosts became available. Eight previously unreported weed species were documented as temporary hosts. A compendium of reported hosts, which includes >160 plant species representing 35 families, for the cotton fleahopper is provided for future research addressing insect-host plant associations. Leading plant families were Asteraceae, Lamiaceae, and Onagraceae. Results presented here indicate a strong argument for assessing weed species diversity and abundance for the control of the cotton fleahopper in the Cotton Belt.